Sentences with phrase «year market cycles»

Prominent Chinese trader, Zhao Dong, has described bitcoin as exhibiting four - year market cycles...

Prominent Chinese trader, Zhao Dong, has described bitcoin as exhibiting four - year market cycles that resemble the seasons in a year, forecasting that the «winter» of cryptocurrency will set - in during 2019.

The beginning of the the book is consumed with 12 - 20 year market cycles.

While there's a great deal of variation across individual market cycles, that's roughly the historical average for a 5.25 year market cycle: a 135 % gain, a 30 % loss, and a 65 % full - cycle return (about 10 % compounded annually, with the full - cycle return coming in at less than half of the bull market gain).

An inordinate share of the money made by investors in a typical five - to 10 - year market cycle materializes in the six months following the bottom.

He anticipates that, across the entirety of a five - to - seven year market cycle, he'll offer his investors somewhat better than average returns with much less heartburn.

Over the 5 - year market cycle, Strategy A earns an average return of 10 % annualized.

Not exact matches

«About a year ago there was the belief that the iPhone X could create a super upgrade cycle and now it appears that the iPhone X is a great high end product but priced too high at $ 999 with memory configurations over $ 1,000 is aimed for the high end market and Apple is positioning its product in various price tiers with high, mid and lower end prices.»

Jurrien Timmer: Yeah, the way that I look at the world, you know, the market cycle has different phases and where we have been for the last few years has really been the Goldilocks, sort of mid-cycle phase.

The fact that Microsoft's Windows 10 won't come to market until later this year — thus hastening the upgrade cycle — will also hurt Intel in the near term, said Alex Gauna, an analyst at JMP Securities, who recently downgraded the stock to «underperform.»

The iPhone cycle will disappoint this year, according to one Wall Street analyst, who issued a rare downgrade of one of the market's most popular stocks.

It said in a note Friday: «With the recent back - up in both IG [investment grade] and HY [high - yield] spreads to their respective 3.5 - year wides, a discussion has emerged about whether the market is sensing the next default cycle around the corner or is simply «overreacting» to some exogenous but ultimately irrelevant events.

On average, the markets have climbed just 4.1 % in the first year of a four - year presidential cycle, with the first quarter seeing the worst return -LRB--- 0.7 %).

Now, bond markets have a habit of having long, long, long cycles, 30, 35 years.

Here again, bull markets have tended to carry on a while — even years of fresh record highs — after the bull / ratio peaks for a cycle.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

It has persisted for more than ten years through market rallies, business cycles, recession, recoveries, and booms.»

Factors that could cause or contribute to actual results differing from our forward - looking statements include risks relating to: failure of DBRS to rate the Notes at the anticipated ratings levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing risks; and other risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.

Ideally you want to look for a firm that has been managing wealth at least ten years because they have experienced a full market cycle.

As we've noted previously, MarketCap / GVA has a correlation of about 92 % with actual subsequent 10 - year S&P 500 total returns, even in recent market cycles.

As you said, the market typically comes in 7 - 10 year cycles, so our current plan is save, save, save... and if the market starts to come down, we might be much more inclined to move cash into a property.

When you look back on this moment in history, remember that many investors ruled out the possibility of major losses over the completion of the current market cycle because they presumed relationships that could not be established in the data, and assumed the absence of any material economic or financial shock in the coming years.

Almost nine years old, both the stock market rally and the US economic growth cycle ought to be mature, but the bull market may have the dynamism to carry prices higher still.

I have no question that these conditions will emerge over the completion of the current market cycle, and - despite the truncated bullish shift and awkward transition that followed my 2009 stress - testing decision - there is not a single market cycle in 30 years as a professional investor where those same conditions did not provoke me to adopt a constructive outlook.

Lite, which has cycled through various campaigns and agencies in recent years, has finally found some marketing consistency.

Since NEC's inception thirteen years ago, our funds have demonstrated strong performance through multiple market cycles and regulatory changes.

Confidently, because 1) we know exactly how our present methods, as well as our pre-2009 methods, have navigated complete market cycles across history, and in real - time prior to this half - cycle, and 2) taking both our present and pre-2009 methods to data from recent years, we also know the «counterfactual» - how our discipline could have navigated the markets since 2009, had my stress - testing decision not bared the Achilles Heel that we addressed in 2014.

The essential thing to understand about valuations is that while they are highly reliable measures of prospective long - term market returns (particularly over 10 - 12 year horizons), and of potential downside risk over the completion of any market cycle, valuations are also nearly useless over shorter segments of the market cycle.

Meanwhile, extreme valuations imply the likelihood of steep market losses over the complete cycle, and also for poor S&P 500 total returns on a 10 - 12 year horizon, but valuations often have little effect on near - term market behavior.

While «overvalued, overbought, overbullish» syndromes were useful in previous market cycles, our reliance on those syndromes in recent years has been detrimental.

Last week, the U.S. equity market climbed to the steepest valuation level in history, based on the valuation measures most highly correlated with actual subsequent S&P 500 10 - 12 year total returns, across a century of market cycles.

Similarly, we've avoided financial stocks during this market cycle, and missed the «private equity» enthusiasm early last year (though again, the decision was clearly vindicated as financials are now at multi-year lows).

The US Securities and Exchange Commission (SEC) has taken action against the fourth Initial Coin Offering (ICO) in the past four months, effectively signaling the end of an era on the cryptocurrency market where shady ICOs have dominated this year's news cycle.

Indeed, even Robert Shiller's cyclically - adjusted P / E (CAPE) is much better correlated with actual subsequent market returns, across a century of market cycles, when we account for the profit margin embedded in the 10 - year average of earnings.

But the problem with that analysis is that you're not taking a 120 - year, modern, economic historical analysis of business cycles and stock market trends.

In recent cycles, because of relatively higher valuations at the market peak, the completion of the market cycle has wiped out years of prior market gains.

That's why most financial people have five - year careers — one market cycle.»

If you combine the two, it happens that the average full market cycle is 5 years in duration, and generates an average total return of about 10.9 % over the entire cycle.

This lends itself to a simple strategy of buying growth stocks after the market has crashed and for several years into a recovery, then shifting to value stocks as interest rates rise and the economic cycle ages.

In my opinion, we will eventually see the end of the current, negative cryptocurrency cycle, as many of the weak hands have been shaken out by the bear market and the remaining investors are on the ready to latch onto any good news after the bad start this year.»

Considering that the stock market has already been rallying for five years since the lows of 2009, it is very possible the bull market has already run its course (every stock market runs in cycles).

On a 12 - year horizon, we project likely S&P 500 nominal total returns averaging close to zero, with the likelihood of an interim market loss on the order of 50 - 60 % over the completion of the current cycle.

Even the most steady and stalwart of tools in the content marketer's arsenal — the editorial calendar — has transformed itself over the years, from a simple spreadsheet for tracking what we publish to an essential component for managing the entire life cycle of our organization's content marketing program.

Table 1 shows the years of each bull - bear cycle, the length of the bull and bear phase, and depth of the following bear market.

Think of it another way, in the last 7 year cycle FCA had an average FCF of $ 36 million a year, and now FCA is expanding into different rail cars types and the refurbishment / rebuilt market, more gigawatts of coal fired power plant capacity will begin construction in 09 then was build in the last 7 years and FCA has $ 162 million in cash from the 05 IPO.

2) By extending the projection horizon by an extra market cycle (~ 6 years - the current half - cycle is quite long - in - the - tooth from a hisorical perspective) the effect of mean reversion has a greater chance to dominate the occasional noise that emerges (e.g. during the tech bubble) over shorter horizons.

One can relate this directly to a 10 - year prospective return by recalling that historical tendency for market cycles to establish normal prospective returns — if even briefly as in 2009 — at their troughs (and it's typical for troughs to reach below average valuations and much higher prospective returns than the 10 % historical norm).

In all probability, December 2015 marked the bottom of the cyclical gold and silver bear market — a bear cycle that had been in play since silver topped in May 2011 and gold in September of the same year.

If one is talking about a complete market cycle, or 10 - 12 year investment prospects, valuations matter unconditionally.

It's an open question whether we'll see that level of prospective return in the next market cycle, but even if we touch that level of prospective returns 5 or 6 years from now, stocks will have gone nowhere in the interim (including dividends).